Sjögren's syndrome

Seminars in Respiratory and Critical Care Medicine

Volumn 28, Issue 4, 2007, Pages 459-472

  Papiris, Spyros A ^a   Tsonis, Ioannis A ^b   Moutsopoulos, Haralampos M ^b  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b LAIKO GENERAL HOSPITAL   (Greece)

Author keywords

Bronchus associated lymphoid tissue hyperplasia; Lymphoepithelial lesions; Lymphoid interstitial pneumonia; Marginal zone B cell lymphoma; Nonspecific interstitial pneumonia

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPRATUZUMAB; IMMUNOMODULATING AGENT; LA ANTIBODY; PREDNISOLONE; RITUXIMAB; RO ANTIBODY; TOLL LIKE RECEPTOR; VINCRISTINE;

AUTOIMMUNE DISEASE; B CELL LYMPHOMA; BRONCHITIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; IMMUNE COMPLEX DEPOSITION; INTERSTITIAL PNEUMONIA; KERATOCONJUNCTIVITIS SICCA; LUNG FUNCTION TEST; LYMPHOID HYPERPLASIA; LYMPHOPROLIFERATIVE DISEASE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NONHODGKIN LYMPHOMA; PATHOGENESIS; PLEURISY; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY TRACT DISEASE; REVIEW; SJOEGREN SYNDROME; THORAX RADIOGRAPHY; VASCULITIS; XEROSTOMIA; INTERSTITIAL LUNG DISEASE; PATHOPHYSIOLOGY;

HUMANS; LUNG DISEASES, INTERSTITIAL; LYMPHOPROLIFERATIVE DISORDERS; PROGNOSIS; RESPIRATORY FUNCTION TESTS; RESPIRATORY TRACT DISEASES; SJOGREN'S SYNDROME;

EID: 35848959920     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-985667     Document Type: Review

References (128)

1. Moutsopoulos H. Sjögren's syndrome. In: Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, eds. Harrison's Principles of Internal Medicine. 14th ed. New York: McGraw-Hill; 2004:1990-1993
2. Moutsopoulos HM. Sjögren's syndrome: autoimmune epithelitis. Clin Immunol Immunopathol 1994;72:162-165
3. Moutsopoulos HM, Chused TM, Mann DL, et al. Sjögren's syndrome (Sicca syndrome): current issues. Ann Intern Med 1980;92:212-226
4. Talal N, Moutsopoulos H, Kassan SS. Sjögren's Syndrome: Clinical and Immunological Aspects. Heidelberg: Springer-Verlag; 1987
5. Kassan SS, Thomas TL, Moutsopoulos HM, et al. Increased risk of lymphoma in sicca syndrome. Ann Intern Med 1978;89:888-892
6. Royer B, Cazals-Hatem D, Sibilia J, et al. Lymphomas in patients with Sjögren's syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses. Blood 1997;90:766-775
7. Talal N, Bunim JJ. The development of malignant lymphoma in the course of Sjoegren's syndrome. Am J Med 1964;36:529-540
8. Voulgarelis M, Dafni UG, Isenberg DA, Moutsopoulos HM. Malignant lymphoma in primary Sjögren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's Syndrome. Arthritis Rheum 1999;42:1765-1772
9. Skopouli FN, Moutsopoulos HM. Autoimmune epithelitis: Sjögren's syndrome. Clin Exp Rheumatol 1994;12 (suppl 11):S9-S11
10. Cairns D, Shelley L, Burke WM, et al. The differing patterns of interstitial lung involvement in connective tissue diseases. J Rheumatol 1992;19:1089-1095
11. Kelly C, Gardiner P, Pal B, Griffiths I. Lung function in primary Sjögren's syndrome: a cross sectional and longitudinal study. Thorax 1991;46:180-183
12. Papiris SA, Kassan SS, Moutsopoulos HM. Lung involvement in primary Sjögren's syndrome. Semin Resp Crit Care Med 1999;20:179-184
13. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-558
14. Manoussakis MN, Moutsopoulos HM. Sjögren's syndrome: autoimmune epithelitis. Baillieres Best Pract Res Clin Rheumatol 2000;14:73-95
15. Sjögren H. Zur Kenntnis de Keraconjunctivitis sicca (Keratitis filiformis bei Hypofunction der Tranendrusen). Acta Opthalmologica 1933;2:1
16. Cha SI, Fessler MB, Cool CD, Schwarz MI, Brown KK. Lymphoid interstitial pneumonia: clinical features, associations and prognosis. Eur Respir J 2006;28:364-369
17. Masaki Y, Sugai S. Lymphoproliferative disorders in Sjögren's syndrome. Autoimmun Rev 2004;3:175-182
18. Papiris SA, Kalomenidis I, Malagari K, et al. Extranodal marginal zone B-cell lymphoma of the lung in Sjögren's syndrome patients: reappraisal of clinical, radiological, and pathology findings. Respir Med 2007;101:84-92
19. Ito I, Nagai S, Kitaichi M, et al. Pulmonary manifestations of primary Sjögren's syndrome: a clinical, radiologic, and pathologic study. Am J Respir Crit Care Med 2005; 171:632-638
20. Parambil JG, Myers JL, Lindell RM, Matteson EL, Ryu JH. Interstitial lung disease in primary Sjögren syndrome. Chest 2006;130:1489-1495
21. Cain HC, Noble PW, Matthay RA. Pulmonary manifestations of Sjögren's syndrome. Clin Chest Med 1998;19:687-699, viii
22. Constantopoulos SH, Papadimitriou CS, Moutsopoulos HM. Respiratory manifestations in primary Sjögren's syndrome: a clinical, functional, and histologic study. Chest 1985;88:226-229
23. Davidson BK, Kelly CA, Griffiths ID. Ten-year follow-up of pulmonary function in patients with primary Sjögren's syndrome. Ann Rheum Dis 2000;59:709-712
24. Hunninghake GW, Fauci AS. Pulmonary involvement in the collagen vascular diseases. Am Rev Respir Dis 1979;119:471-503
25. Papathanasiou MP, Constantopoulos SH, Tsampoulas C, Drosos AA, Moutsopoulos HM. Reappraisal of respiratory abnormalities in primary and secondary Sjögren's syndrome: a controlled study. Chest 1986;90:370-374
26. Segal I, Fink G, Machtey I, Gura V, Spitzer SA. Pulmonary function abnormalities in Sjögren's syndrome and the sicca complex. Thorax 1981;36:286-289
27. Gardiner P. Primary Sjögren's syndrome. Baillieres Clin Rheumatol 1993;7:59-77
28. Mialon P, Barthelemy L, Sebert P, et al. A longitudinal study of lung impairment in patients with primary Sjögren's syndrome. Clin Exp Rheumatol 1997;15:349-354
29. Franquet T, Gimenez A, Monill JM, Diaz C, Geli C. Primary Sjögren's syndrome and associated lung disease: CT findings in 50 patients. AJR Am J Roentgenol 1997;169:655-658
30. Uffmann M, Kiener HP, Bankier AA, et al. Lung manifestation in asymptomatic patients with primary Sjögren syndrome: assessment with high resolution CT and pulmonary function tests. J Thorac Imaging 2001; 16:282-289
31. Dalavanga YA, Constantopoulos SH, Galanopoulou V, Zerva L, Moutsopoulos HM. Alveolitis correlates with clinical pulmonary involvement in primary Sjögren's syndrome. Chest 1991;99:1394-1397
32. Hatron PY, Wallaert B, Gosset D, et al. Subclinical lung inflammation in primary Sjögren's syndrome: relationship between bronchoalveolar lavage cellular analysis findings and characteristics of the disease. Arthritis Rheum 1987;30:1226-1231
33. Adamson TC III, Fox RI, Frisman DM, Howell FV. Immunohistologic analysis of lymphoid infiltrates in primary Sjögren's syndrome using monoclonal antibodies. J Immunol 1983;130:203-208
34. Brookes SM, Price EJ, Venables PJ, Maini RN. Interferon-gamma and epithelial cell activation in Sjögren's syndrome. Br J Rheumatol 1995;34:226-231
35. Fox RI, Theofilopoulos AN, Altman A. Production of interleukin 2 (IL 2) by salivary gland lymphocytes in Sjögren's syndrome: detection of reactive cells by using antibody directed to synthetic peptides of IL 2. J Immunol 1985;135:3109-3115
36. Moutsopoulos HM, Hooks JJ, Chan CC, et al. HLA-DR expression by labial minor salivary gland tissues in Sjögren's syndrome. Ann Rheum Dis 1986;45:677-683
37. Papiris SA, Saetta M, Turato G, et al. CD4-positive T-lymphocytes infiltrate the bronchial mucosa of patients with Sjögren's syndrome. Am J Respir Crit Care Med 1997;156:637-641
38. Xanthou G, Polihronis M, Tzioufas AG, et al. "Lymphoid" chemokine messenger RNA expression by epithelial cells in the chronic inflammatory lesion of the salivary glands of Sjögren's syndrome patients: possible participation in lymphoid structure formation. Arthritis Rheum 2001;44:408-418
39. Xanthou G, Tapinos NI, Polihronis M, et al. CD4 cytotoxic and dendritic cells in the immunopathologic lesion of Sjögren's syndrome. Clin Exp Immunol 1999;118:154-163
40. Manoussakis MN. Immunological and clinical predictors for lymphoma in Sjögren's syndrome [abstract SP0013]. Ann Rheum Dis 2006;65(Suppl 2):6
41. Moutsopoulos HM, Tzioufas AG, Bai MK, Papadopoulos NM, Papadimitriou CS. Association of serum IgM kappa monoclonicity in patients with Sjögren's syndrome with an increased proportion of kappa positive plasma cells infiltrating the labial minor salivary glands. Ann Rheum Dis 1990;49:929-931
42. Tengner P, Halse AK, Haga HJ, Jonsson R, Wahren-Herlenius M. Detection of anti-Ro/SSA and anti-La/SSB autoantibody-producing cells in salivary glands from patients with Sjögren's syndrome. Arthritis Rheum 1998;41:2238-2248
43. Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994;179:1317-1330
44. Kapsogeorgou EK, Abu-Helu RF, Moutsopoulos HM, Manoussakis MN. Salivary gland epithelial cell exosomes: a source of autoantigenic ribonucleoproteins. Arthritis Rheum 2005;52:1517-1521
45. Skopouli FN, Kousvelari EE, Mertz P, et al. c-myc mRNA expression in minor salivary glands of patients with Sjögren's syndrome. J Rheumatol 1992;19:693-699
46. Tapinos NI, Polihronis M, Moutsopoulos HM. Lymphoma development in Sjögren's syndrome: novel p53 mutations. Arthritis Rheum 1999;42:1466-1472
47. de Wilde PC, Kater L, Bodeutsch C, et al. Aberrant expression pattern of the SS-B/La antigen in the labial salivary glands of patients with Sjögren's syndrome. Arthritis Rheum 1996;39:783-791
48. Yannopoulos DI, Roncin S, Lamour A, et al. Conjunctival epithelial cells from patients with Sjögren's syndrome inappropriately express major histocompatibility complex molecules, La(SSB) antigen, and heat-shock proteins. J Clin Immunol 1992;12:259-265
49. Kapsogeorgou EK, Dimitriou ID, Abu-Helu RF, Moutsopoulos HM, Manoussakis MN. Activation of epithelial and myoepithelial cells in the salivary glands of patients with Sjögren's syndrome: high expression of intercellular adhesion molecule-1 (ICAM.1) in biopsy specimens and cultured cells. Clin Exp Immunol 2001;124:126-133
50. Boumba D, Skopouli FN, Moutsopoulos HM. Cytokine mRNA expression in the labial salivary gland tissues from patients with primary Sjögren's syndrome. Br J Rheumatol 1995;34:326-333
51. Fox RI, Bumol T, Fantozzi R, Bone R, Schreiber R. Expression of histocompatibility antigen HLA-DR by salivary gland epithelial cells in Sjögren's syndrome. Arthritis Rheum 1986;29:1105-1111
52. Lindahl G, Hedfors E, Klareskog L, Forsum U. Epithelial HLA-DR expression and T lymphocyte subsets in salivary glands in Sjögren's syndrome. Clin Exp Immunol 1985;61:475-482
53. Kapsogeorgou EK, Moutsopoulos HM, Manoussakis MN. Functional expression of a costimulatory B7.2 (CD86) protein on human salivary gland epithelial cells that interacts with the CD28 receptor, but has reduced binding to CTLA4. J Immunol 2001;166:3107-3113
54. Manoussakis MN, Dimitriou ID, Kapsogeorgou EK, et al. Expression of B7 costimulatory molecules by salivary gland epithelial cells in patients with Sjögren's syndrome. Arthritis Rheum 1999;42:229-239
55. Dimitriou ID, Kapsogeorgou EK, Moutsopoulos HM, Manoussakis MN. CD40 on salivary gland epithelial cells: high constitutive expression by cultured cells from Sjögren's syndrome patients indicating their intrinsic activation. Clin Exp Immunol 2002;127:386-392
56. Spachidou MP, Bourazopoulou E, Kapsogeorgou EK, et al. Functional Toll-like receptors (TLRs) are expressed by cultured salivary gland epithelial cells: increased mRNA expression of TLR -1, -2 and -4 in cells derived from patients with primary Sjögren's syndrome [abstract 684]. Arthritis Rheum 2005;52:278
57. Triantafyllopoulou A, Tapinos N, Moutsopoulos HM. Evidence for coxsackievirus infection in primary Sjögren's syndrome. Arthritis Rheum 2004;50:2897-2902
58. Harris SR, Mark EJ. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises: case 17-2001: a 42-year-old man with multiple pulmonary cysts and recurrent respiratory infections. N Engl J Med 2001;344:1701-1708
59. Constantopoulos SH, Drosos AA, Maddison PJ, Moutsopoulos HM. Xerotrachea and interstitial lung disease in primary Sjögren's syndrome. Respiration 1984;46:310-314
60. Ellman P, Parkes Weber F. Sjögren's disease with dryness of the bronchial mucosa and uncertain lung lesion. BMJ 1949;1:304-305
61. Ellman P, Parkes Weber F, Goddier TEW. A contribution to the pathology of Sjögren's syndrome. QJ Med 1951;77:33-43
62. Andoh Y, Shimura S, Sawai T, et al. Morphometric analysis of airways in Sjögren's syndrome. Am Rev Respir Dis 1993;148:1358-1362
63. Strimlan CV, Rosenow EC III, Divertie MB, Harrison EG Jr. Pulmonary manifestations of Sjögren's syndrome. Chest 1976;70:354-361
64. Newball HH, Brahim SA. Chronic obstructive airway disease in patients with Sjögren's syndrome. Am Rev Respir Dis 1977;115:295-304
65. Oxholm P, Bundgaard A, Birk Madsen E, Manthorpe R, Vejlo Rasmussen F. Pulmonary function in patients with primary Sjögren's syndrome. Rheumatol Int 1982;2:179-181
66. Bariffi F, Pesci A, Bertorelli G, Manganelli P, Ambanelli U. Pulmonary involvement in Sjögren's syndrome. Respiration 1984;46:82-87
67. Potena A, La Corte R, Fabbri LM, et al. Increased bronchial responsiveness in primary and secondary Sjögren's syndrome. Eur Respir J 1990;3:548-553
68. Gudbjornsson B, Hedenstrom H, Stalenheim G, Hallgren R. Bronchial hyperresponsiveness to methacholine in patients with primary Sjögren's syndrome. Ann Rheum Dis 1991;50:36-40
69. Gardiner P, Ward C, Allison A, et al. Pleuropulmonary abnormalities in primary Sjögren's syndrome. J Rheumatol 1993;20:831-837
70. Lahdensuo A, Korpela M. Pulmonary findings in patients with primary Sjögren's syndrome. Chest 1995;108:316-319
71. Salaffi F, Manganelli P, Carotti M, et al. A longitudinal study of pulmonary involvement in primary Sjögren's syndrome: relationship between alveolitis and subsequent lung changes on high-resolution computed tomography. Br J Rheumatol 1998;37:263-269
72. Franquet T, Diaz C, Domingo P, Gimenez A, Geli C. Air trapping in primary Sjögren syndrome: correlation of expiratory CT with pulmonary function tests. J Comput Assist Tomogr 1999;23:169-173
73. Ludviksdottir D, Janson C, Hogman M, et al. Increased nitric oxide in expired air in patients with Sjögren's syndrome. BHR study group: bronchial hyperresponsiveness. Eur Respir J 1999;13:739-743
74. Papiris SA, Maniati M, Constantopoulos SH, et al. Lung involvement in primary Sjögren's syndrome is mainly related to the small airway disease. Ann Rheum Dis 1999;58:61-64
75. Taouli B, Brauner MW, Mourey I, Lemouchi D, Grenier PA. Thin-section chest CT findings of primary Sjögren's syndrome: correlation with pulmonary function. Eur Radiol 2002;12:1504-1511
76. Pertovaara M, Korpela M, Saarelainen S, et al. Long-term follow-up study of pulmonary findings in patients with primary Sjögren's syndrome. Scand J Rheumatol 2004;33:343-348
77. Dalavanga YA, Voulgari PV, Georgiadis AN, et al. Lymphocytic alveolitis: a surprising index of poor prognosis in patients with primary Sjögren's syndrome. Rheumatol Int 2006;26:799-804
78. Whaley K, Webb J, McAvoy BA, et al. Sjögren's syndrome, II: Clinical associations and immunological phenomena. QJ Med 1973;42:513-548
79. Silbiger ML, Peterson CC Jr. Sjögren's syndrome: its roentgenographic features. Am J Roentgenol Radium Ther Nucl Med 1967;100:554-558
80. Meyer CA, Pina JS, Taillon D, Godwin JD. Inspiratory and expiratory high-resolution CT findings in a patient with Sjögren's syndrome and cystic lung disease. AJR Am J Roentgenol 1997;168:101-103
81. Johkoh T, Muller NL, Pickford HA, et al. Lymphocytic interstitial pneumonia: thin-section CT findings in 22 patients. Radiology 1999;212:567-572
82. Sutinen S, Sutinen S, Huhti E. Ultrastructure of lymphoid interstitial pneumonia: virus-like particles in bronchiolar epithelium of a patient with Sjögren's syndrome. Am J Clin Pathol 1977;67:328-333
83. Yousem SA, Colby TV, Carrington CB. Follicular bronchitis/bronchiolitis. Hum Pathol 1985;16:700-706
84. Colby TV. Pulmonary pathology in patients with systemic autoimmune diseases. Clin Chest Med 1998;19:587-612, vii
85. Zulman J, Jaffe R, Talal N. Evidence that the malignant lymphoma of Sjögren's syndrome is a monoclonal B-cell neoplasm. N Engl J Med 1978;299:1215-1220
86. Colby TV, Carrington CB. Lymphoreticular tumors and infiltrates of the lung. Pathol Annu 1983;18(Pt 1):27-70
87. Anderson LG, Talal N. The spectrum of benign to malignant lymphoproliferation in Sjögren's syndrome. Clin Exp Immunol 1972;10:199-221
88. Bonner HJr, ,Ennis RS, Geelhoed GW, Tarpley TM Jr. Lymphoid infiltration and amyloidosis of lung in Sjögren's syndrome. Arch Pathol 1973;95:42-44
89. Liebow AA, Carrington CB. Diffuse pulmonary lymphoreticular infiltrations associated with dysproteinemia. Med Clin North Am 1973;57:809-843
90. Fortoul TI, Cano-Valle F, Oliva E, Barrios R. Follicular bronchiolitis in association with connective tissue diseases. Lung 1985;163:305-314
91. Katzenstein AL. Primary lymphoid lung lesions. In: Katzenstein AL, ed. Katzenstein and Asian's surgical pathology of nonneoplastic lung disorders. 3rd ed. Philadelphia: Saunders; 1997:223-246
92. Kobayashi H, Matsuoka R, Kitamura S, Tsunoda N, Saito K. Sjögren's syndrome with multiple bullae and pulmonary nodular amyloidosis. Chest 1988;94:438-440
93. Mariette X. Lymphomas in patients with Sjögren's syndrome: review of the literature and physiopathologic hypothesis. Leuk Lymphoma 1999;33:93-99
94. Agostini C, Chilosi M, Zambello R, Trentin L, Semenzato G. Pulmonary immune cells in health and disease: lymphocytes. Eur Respir J 1993;6:1378-1401
95. Sakamoto O, Saita N, Ando M, et al. Two cases of Sjögren's syndrome with multiple bullae. Intern Med 2002;41:124-128
96. Hubscher O, Re R, Iotti R. Cystic lung disease in Sjögren's syndrome. J Rheumatol 2002;29:2235-2236
97. Wells AU, du Bois RM. Bronchiolitis in association with connective tissue disorders. Clin Chest Med 1993;14:655-666
98. Swigris JJ, Berry GJ, Raffin TA, Kuschner WG. Lymphoid interstitial pneumonia: a narrative review. Chest 2002;122:2150-2164
99. Saltzstein SL. Pulmonary malignant lymphomas and pseudolymphomas: classification, therapy, and prognosis. Cancer 1963;16:928-955
100. Liebow AA, Carrington CR, Friedman PJ. Lymphomatoid granulomatosis. Hum Pathol 1972;3:457-558
101. Katzenstein AL, Carrington CB, Liebow AA. Lymphomatoid granulomatosis: a clinicopathologic study of 152 cases. Cancer 1979;43:360-373
102. Weisbrot IM. Lymphomatoid granulomatosis of the lung, associated with a long history of benign lymphoepithelial lesions of the salivary glands and lymphoid interstitial pneumonitis: report of a case. Am J Clin Pathol 1976;66:792-801
103. Ioannidis JP, Vassiliou VA, Moutsopoulos HM. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome. Arthritis Rheum 2002;46:741-747
104. Kamholz S, Sher A, Barland P, et al. Sjögren's syndrome: severe upper airways obstruction due to primary malignant tracheal lymphoma developing during successful treatment of lymphocytic interstitial pneumonitis. J Rheumatol 1987;14:588-594
105. Theander E, Henriksson G, Ljungberg O, et al. Lymphoma and other malignancies in primary Sjögren's syndrome: a cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis 2006;65:796-803
106. Honda O, Johkoh T, Ichikado K, et al. Differential diagnosis of lymphocytic interstitial pneumonia and malignant lymphoma on high-resolution CT. AJR Am J Roentgenol 1999;173:71-74
107. Deheinzelin D, Capelozzi VL, Kairalla RA, et al. Interstitial lung disease in primary Sjögren's syndrome: clinical-pathological evaluation and response to treatment. Am J Respir Crit Care Med 1996;154:794-799
108. Yamadori I, Fujita J, Bandoh S, et al. Nonspecific interstitial pneumonia as pulmonary involvement of primary Sjögren's syndrome. Rheumatol Int 2002;22:89-92
109. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002;165:277-304
110. Epler GR, Colby TV, McLoud TC, Carrington CB, Gaensler EA. Bronchiolitis obliterans organizing pneumonia. N Engl J Med 1985;312:152-158
111. Matteson EL, Ike RW. Bronchiolitis obliterans organizing pneumonia and Sjögren's syndrome. J Rheumatol 1990;17:676-679
112. Usui Y, Kimula Y, Miura H, et al. A case of bronchiolitis obliterans organizing pneumonia associated with primary Sjögren's syndrome who died of superimposed diffuse alveolar damage. Respiration 1992;59:122-124
113. Homma H, Yamanaka A, Tanimoto S, et al. Diffuse panbronchiolitis: a disease of the transitional zone of the lung. Chest 1983;83:63-69
114. Okano A, Sato A, Suda T, et al. A case of diffuse panbronchiolitis complicated by malignant thymoma and Sjögren's syndrome. Nihon Kyobu Shikkan Gakkai Zasshi 1991;29:263-268
115. Ubukata M, Sugiyama S, Ohno S, Sugama Y, Kitamura S. A case of Sjögren's syndrome with a clinical course similar to diffuse panbronchiolitis. Nihon Kyobu Shikkan Gakkai Zasshi 1991;29:387-391
116. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises: case 23-1975. N Engl J Med 1975;292:1285-1290
117. Sugai S. Mucosa-associated lymphoid tissue (MALT) lymphoma and primary amyloidosis in the lung in Sjögren's syndrome. Intern Med 2002;41:251-252
118. Alvarez-Sala R, Sanchez-Toril F, Garcia-Martinez J, Zaera A, Masa JF. Primary Sjögren syndrome and pleural effusion. Chest 1989;96:1440-1441
119. Ogihara T, Nakatani A, Ito H, et al. Sjögren's syndrome with pleural effusion. Intern Med 1995;34:811-814
120. Skopouli FN, Dafni U, Ioannidis JP, Moutsopoulos HM. Clinical evolution, and morbidity and mortality of primary Sjögren's syndrome. Semin Arthritis Rheum 2000;29:296-304
121. Manoussakis MN, Moutsopoulos HM. Sjögren's syndrome: current concepts. Adv Intern Med 2001;47:191-217
122. Edwards JC, Cambridge G. B-cell targeting in rheumatoid arthritis and other autoimmune diseases. Nat Rev Immunol 2006;6:394-403
123. Pijpe J, van Imhoff GW, Spijkervet FK, et al. Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II study. Arthritis Rheum 2005;52:2740-2750
124. Seror R, Sordet C, Guillevin L, et al. Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren's syndrome. Ann Rheum Dis 2007;66:351-357
125. Steinfeld SD, Tant L, Burmester GR, et al. Epratuzumab (humanised anti-CD22 antibody) in primary Sjögren's syndrome: an open-label phase I/II study. Arthritis Res Ther 2006;8:R129-R139
126. Swords R, Power D, Fay M, O'Donnell R, Murphy PT. Interstitial pneumonitis following rituximab therapy for immune thrombocytopenic purpura (ITP). Am J Hematol 2004;77:103-104
127. Brown SL, Miller RA, Horning SJ, et al. Treatment of B-cell lymphomas with anti-idiotype antibodies alone and in combination with alpha interferon. Blood 1989;73:651-661
128. Voulgarelis M, Giannouli S, Tzioufas AG, Moutsopoulos HM. Long term remission of Sjögren's syndrome associated aggressive B cell non-Hodgkin's lymphomas following combined B cell depletion therapy and CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone). Ann Rheum Dis 2006;65:1033-1037